Side effects of frequently used oral antidiabetics on wound healing in vitro
Standard
Side effects of frequently used oral antidiabetics on wound healing in vitro. / Stuermer, Ewa Klara; Besser, M; Terberger, N; Koester, V; Bachmann, H S; Severing, A L.
In: N-S ARCH PHARMACOL, Vol. 392, No. 3, 03.2019, p. 371-380.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Side effects of frequently used oral antidiabetics on wound healing in vitro
AU - Stuermer, Ewa Klara
AU - Besser, M
AU - Terberger, N
AU - Koester, V
AU - Bachmann, H S
AU - Severing, A L
PY - 2019/3
Y1 - 2019/3
N2 - Lifestyle diseases such as diabetes and arteriosclerosis are rising in the increasingly aging society, and the number of patients with daily intake of glucose-lowering medication has also increased. Interestingly, knowledge about oral antidiabetics with regard to wound healing is scarce. Therefore, the aim of this study was to identify possible (side) effects of the most frequently prescribed oral antidiabetics on skin cells and wound healing. Four oral antidiabetics of different substance classes (i.e., metformin, glibenclamide, sitagliptin, repaglinide) were investigated with regard to the promotion of cell metabolism and migration of human skin fibroblasts and keratinocytes by XTT and scratch assays. In addition, histological and immunohistochemical analyses were performed in a 3D wound model to address the impact of the antidiabetics on regeneration processes, such as cell migration, fibroblast activity, epidermal thickness, and cell apoptosis. In comparison to systemic application, metformin displayed the most adverse effects in vitro in nearly all analyses, interestingly at serum equivalent concentrations. In contrast, sitagliptin and glibenclamide had a slight but insignificant effect on fibroblasts compared with keratinocytes. Repaglinide tended to have a negative influence on keratinocyte metabolism. Interestingly, antidiabetics generally induced a significantly enhanced rate of apoptosis in fibroblasts, with the exception of repaglinide.Antidiabetics influenced key players in wound healing, namely, keratinocytes and fibroblasts. Particularly, metformin impaired human skin cells. These findings should be kept in mind in further studies because of their putative relevance in patients suffering from chronic wounds that do not respond to various wound therapies.
AB - Lifestyle diseases such as diabetes and arteriosclerosis are rising in the increasingly aging society, and the number of patients with daily intake of glucose-lowering medication has also increased. Interestingly, knowledge about oral antidiabetics with regard to wound healing is scarce. Therefore, the aim of this study was to identify possible (side) effects of the most frequently prescribed oral antidiabetics on skin cells and wound healing. Four oral antidiabetics of different substance classes (i.e., metformin, glibenclamide, sitagliptin, repaglinide) were investigated with regard to the promotion of cell metabolism and migration of human skin fibroblasts and keratinocytes by XTT and scratch assays. In addition, histological and immunohistochemical analyses were performed in a 3D wound model to address the impact of the antidiabetics on regeneration processes, such as cell migration, fibroblast activity, epidermal thickness, and cell apoptosis. In comparison to systemic application, metformin displayed the most adverse effects in vitro in nearly all analyses, interestingly at serum equivalent concentrations. In contrast, sitagliptin and glibenclamide had a slight but insignificant effect on fibroblasts compared with keratinocytes. Repaglinide tended to have a negative influence on keratinocyte metabolism. Interestingly, antidiabetics generally induced a significantly enhanced rate of apoptosis in fibroblasts, with the exception of repaglinide.Antidiabetics influenced key players in wound healing, namely, keratinocytes and fibroblasts. Particularly, metformin impaired human skin cells. These findings should be kept in mind in further studies because of their putative relevance in patients suffering from chronic wounds that do not respond to various wound therapies.
KW - Administration, Oral
KW - Apoptosis/drug effects
KW - Carbamates/pharmacology
KW - Caspases/metabolism
KW - Cell Line
KW - Fibroblasts/drug effects
KW - Gelatinases/metabolism
KW - Glyburide/pharmacology
KW - Humans
KW - Hypoglycemic Agents/adverse effects
KW - Keratinocytes/drug effects
KW - Membrane Proteins/metabolism
KW - Metformin/pharmacology
KW - Piperidines/pharmacology
KW - Receptors, CXCR4/metabolism
KW - Serine Endopeptidases/metabolism
KW - Sitagliptin Phosphate/pharmacology
KW - Wound Healing/drug effects
U2 - 10.1007/s00210-018-01597-9
DO - 10.1007/s00210-018-01597-9
M3 - SCORING: Journal article
C2 - 30535571
VL - 392
SP - 371
EP - 380
JO - N-S ARCH PHARMACOL
JF - N-S ARCH PHARMACOL
SN - 0028-1298
IS - 3
ER -
